Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Pulmonary hypertension or elevated blood pressure in the lung caused by left heart diseases such as mitral valve stenosis is classified as Group 2 under the World Health Organization pulmonary hypertension classification system. Group 2 pulmonary hypertension is the most common type of pulmonary hypertension, but currently there is no approved therapies for this disease. To develop effective therapies for Group 2 pulmonary hypertension, an animal model is required. Fujimoto et al. recently developed a novel Group 2 pulmonary hypertension rat model by partially banding the left atrium with a metal clip to increase the left atrial and pulmonary venous pressure, which mimic mitral valve stenosis in human. Mitochondria, the power house of the cell, are found to be disordered in many diseases such as cardiovascular disease, neurodegenerative disease, and cancer. TO BE CONT’D
Stephen Archer
The Jikei University School of Medicine
Life Sciences
Queen's University
Globalink Research Award
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.